The biologics industry is facing growing pressure to improve downstream processing as high-productivity manufacturing, continuous bioprocessing, biosimilars, and advanced therapies such as cell and gene therapies increase process complexity. Many downstream processing teams still rely on Excel-based data capture and reporting, making it difficult to efficiently compare chromatography data from systems such as ÄKTA UNICORN with analytical results like HPLC testing. These manual processes are time-consuming, prone to transcription errors, and can limit process understanding. IDBS Polar BioProcess addresses these challenges by seamlessly integrating process and analytical data within standardized digital workflows. The platform enables teams to capture, connect, and analyze data throughout do

Join for free to read